ACR Convergence

Many rheumatologists may not be trained to properly identify the signs of skin disease in patients with dark skin, but in this ACR Convergence session, experts provide practical guidance for diagnosis.

At this ACR Convergence 2024 session, the focus was on the identification & treatment of a newly identified syndrome of undifferentiated recurrent fever (SURF).

The ACR honored 19 members for outstanding contributions to the ACR and the field of rheumatology.

Experts address how sex differences affect the clinical presentation, diagnosis, response to therapy and experience of illness for patients with PsA.

Experts shared insights into their work on building consensus for the use of musculoskeletal ultrasound for the diagnosis and management of RA and PsA.

Experts addressed how education and follow-up for patients with gout can improve disease management and highlighted the need for a better construction of gout remission.

In the Medical Education Year in Review session at ACR Convergence 2024, David Leverenz, MD, MEd, discussed the current make-up of rheumatology, how competency is measured and how to help rheumatology fellows thrive.

Dr. Khaled Elsaid discussed synovial macrophages/monocytes and monosodium urate crystal interactions at a session during ACR Convergence, exploring potential new gout pharmacology targets via the lubricin/CD44/protein phosphatase 2A (PP2A) pathway.

At this ACR Convergence 2024 session, two experts spoke about identifying difficult-to-manage patients with spondyloarthritis, differentiating active disease from fibromyalgia & therapy selection in these patients.

The 2024 Dubois Memorial Lecture focused on health inequities with lupus & strategies to close the gap.